en
Feedback
B pharma 1 2 3 4 5 6 7 8 sem(GPAT)

B pharma 1 2 3 4 5 6 7 8 sem(GPAT)

Open in Telegram

📈 Analytical overview of Telegram channel B pharma 1 2 3 4 5 6 7 8 sem(GPAT)

Channel B pharma 1 2 3 4 5 6 7 8 sem(GPAT) (@bpharma1234567semesternotes) in the English language segment is an active participant. Currently, the community unites 10 288 subscribers, ranking 19 003 in the Education category and 37 152 in the India region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 10 288 subscribers.

According to the latest data from 07 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -81 over the last 30 days and by -4 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 27.73%. Within the first 24 hours after publication, content typically collects 4.32% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 2 853 views. Within the first day, a publication typically gains 444 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 2.
  • Thematic interests: Content is focused on key topics such as semester, 3rd, pharma, 6th, बनाएँ.

📝 Description and content policy

Channel description not provided.

Thanks to the high frequency of updates (latest data received on 08 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Education category.

10 288
Subscribers
-424 hours
-277 days
-8130 days
Posts Archive
Regarding Declaration of Challenge Evaluation Results for the Even Semester Examination, Session 2025–26.
Regarding Declaration of Challenge Evaluation Results for the Even Semester Examination, Session 2025–26.

AKTU Degree, Marksheet Related Circular.pdf

📚 B.Pharm Premium Handwritten Notes Easy Language • All Subjects Covered • Exam Ready 💯 💰 Price List: 1st / 2nd Sem — ₹51 3rd Sem — ₹69 4th Sem — ₹79 5th Sem — ₹99 6th Sem — ₹107 7th Sem — ₹99 8th Sem — ₹99 📩 Buy karne ke liye DM karein: @EmmigradionD

📚 B.Pharm Premium Handwritten Notes Easy Language • All Subjects Covered • Exam Ready 💯 💰 Price List: 1st / 2nd Sem — ₹51 3rd Sem — ₹69 4th Sem — ₹79 5th Sem — ₹99 6th Sem — ₹107 7th Sem — ₹99 8th Sem — ₹99 📩 Buy karne ke liye DM karein: @EmmigradionD

📚 B.Pharm Premium Handwritten Notes Easy Language • All Subjects Covered • Exam Ready 💯 💰 Price List: 1st / 2nd Sem — ₹51 3rd Sem — ₹69 4th Sem — ₹79 5th Sem — ₹99 6th Sem — ₹107 7th Sem — ₹99 8th Sem — ₹99 📩 Buy karne ke liye DM karein: @EmmigradionD

21/08/26 to 24/08/26 Regarding Reopening of the ERP Portal for Students of the Even Semester Examination, Session 2025–26, to
21/08/26 to 24/08/26 Regarding Reopening of the ERP Portal for Students of the Even Semester Examination, Session 2025–26, to Apply for Challenge Evaluation (Stage–II).

Challenge Evaluation Portal Reopen 18 & 19 August 2026
Challenge Evaluation Portal Reopen 18 & 19 August 2026

Regarding Challenge Evaluation Stage - 2
Regarding Challenge Evaluation Stage - 2

Regarding students (excluding final-year students) of the Even Semester Session 2025–26 whose Practical Examination Marks have not been uploaded online.

210341vqmqwn0j.pdf

Regarding Conduct of Online Classes for the Academic Session 2026–27
Regarding Conduct of Online Classes for the Academic Session 2026–27

#RIP Dharmendra Pradhan

UP SCHOLARSHIP 2026-27 TIME TABLE

91-2026-1941-26-3-2026-1741061 Mail.pdf

Regarding Challenge Evaluation (Stage–I) for Even Semester, Session 2025–26.

2102901zt4l3wq.pdf

B.pharm 2nd and 4th Sem Result out

STOP No More Warnings No further warnings will be given. Anyone found violating the group rules from this point onward will be removed and blocked immediately. This group is strictly for studies and academic discussions only.